Phase 1 Cutaneous Squamous Cell Carcinoma (CSCC) Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors

Cutaneous MelanomaMerkel Cell Carcinoma of SkinBasal Cell Carcinoma of Skin+2 more

Kupando GmbH21 enrolled2 locationsNCT07600476

Recruiting

Phase 1

A Study of VET3-TGI in Patients With Solid Tumors

Cervical CancerNon-small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+10 more

KaliVir Immunotherapeutics60 enrolled7 locationsNCT06444815